Carl Icahn News
Most Popular Carl Icahn Story
Byetta uptick, Icahn news boost Amylin
Maybe Amylin Pharmaceuticals isn't so bad off after all. With Carl Icahn boosting his stake in the company and Byetta sales reversing their downward slide, industry observers are taking another look... Read more...
Latest Headlines
- November 18, 2008
- October 20, 2008
- October 7, 2008
- October 6, 2008
- October 1, 2008
- September 26, 2008
- September 24, 2008
- September 15, 2008
- September 12, 2008
- September 10, 2008
- August 12, 2008
- August 5, 2008
- August 4, 2008
- June 5, 2008
- May 23, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
